NOTICE OF ALLOWANCE - ISSUED
issued
on 05 Nov 2024
Last Applicant/ Owned by
10230 Jasper Avenue
Edmonton, Alberta
CA
T5J4P6
Serial Number
97590585 filed on 14th Sep 2022
Registration Number
N/A
Correspondent Address
Theodore R. Remaklus
Filing Basis
1. intent to use current
2. filed as use application
Disclaimer
NO DATA
ENTOS
Medical devices for the qualitative detection and testing of DNA and RNA in human specimens for the detection of influenzaviruses and nucleic acid detection Reagents for scientific purposes for use in nucleic acid isolation and purification; cell culture media for laboratory use for use inthe biotechnological industry; diagnostic reagents for clinical laboratory use; diagnostic preparations for c Read More
Classification Information
Class [010]
Medical Instrument Products
Medical devices for the qualitative detection and testing of DNA and RNA in human specimens for the detection of influenzaviruses and nucleic acid detection
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [009]
Computer & Software Products & Electrical & Scientific Products
Nucleic acid sequencers for scientific purposes
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [005]
Pharmaceutical Products
Pharmaceutical and medicinal preparations and substances, namely, human vaccines, therapeutic proteins and antibodies for thetreatment of infectious diseases, namely, viral infections, bacterial infections, fungal infections, parasitic infections and priondiseases, infections of multiple organ systems namely, the lung in the name of pneumonia, kidneys in the name of pyelonephritis,gastrointestinal track in the nature of gastritis, enteritis, colitis, systemic blood infections in the nature of sepsis/septic shock, skininfections in the nature of cellulitis, central nervous system in the nature of meningitis, encephalitis, walled off infections in thenature of abscesses, liver in the nature of hepatitis, head and neck infections in the nature of conjunctivitis, uveitis, sinusitis;chronic diseases, namely, chronic neurological and nervous system diseases and other mental illnesses, chronic respiratory,pulmonary and lung diseases, chronic inflammatory diseases, chronic cardiovascular diseases, chronic liver diseases, chronickidney diseases, chronic bone diseases, chronic eye diseases, chronic oral diseases, chronic blood diseases, chronic spleendiseases, chronic pancreatic diseases, chronic thyroid diseases, chronic reproductive disease, chronic gastrointestinal diseases,chronic skin diseases, chronic muscle diseases, chronic bone diseases and cancers in the nature of hematological cancers andsolid organ cancers; vaccines that are viral, bacterial, fungal for human use; vaccines that are viral, bacterial, fungal for veterinaryuse; therapeutic and preventative cancer vaccines for human use; therapeutic and preventative cancer vaccines for veterinaryuse; diagnostic preparations for medical purposes for detecting genetic predispositions; pharmaceutical preparations for thetreatment of genetic disorders; pharmaceutical preparations for the diagnosis, treatment and prevention of a variety of diseasesand disorders, namely, cancer, inflammatory diseases and disorders, namely, inflammatory bowel diseases and disorders,inflammatory connective tissue diseases and disorders, inflammatory pelvic diseases and disorders, inflammatory musclediseases and disorders, asthma, coeliac disease, hepatitis which is viral, alcoholic, autoimmune, inflammatory bowel disease,namely Crohn's and ulcerative colitis, fatty liver disease, diabetes, endometriosis, arthritis, obesity, autoimmune diseases anddisorders, metabolic diseases and disorders, namely, metabolic enzyme deficiencies, diabetes, hypoglycemia, gout, osteoarthritis,muscular dystrophy, anemia, genetic diseases and disorders, infectious diseases, namely, blood infections, respiratory infections,topical infections, cardiovascular diseases and disorders, neurological diseases and disorders, namely, Alzheimer's, Huntington'sDisease, cerebral palsy, brain injury, spinal cord injury and seizure disorders, hematological diseases and disorders,dermatological diseases and disorders, namely, dermatitis, skin pigmentation diseases, psoriasis, eczema, acne, shingles, hives,rosacea, ophthalmological diseases and disorders, gastrointestinal diseases and disorders, genitourinary diseases and disorders,namely, urological diseases and disorders, infertility, sexually transmitted diseases, acute renal failure, benign ptostatichyperplasia, endometrial ablation, renal diseases and disorders, respiratory diseases and disorders, connective tissues diseasesand disorders, and enzyme deficiency diseases and disorders, rare and orphan diseases, and rare genetic diseases anddisorders, namely, rare neurological and nervous system diseases and other mental illnesses, rare respiratory, pulmonary andlung diseases, rare inflammatory diseases, rare cardiovascular diseases, rare liver diseases, rare kidney diseases, rare bonediseases, rare eye diseases, rare oral diseases, rare blood diseases, rare spleen diseases, rare pancreatic diseases, rare thyroiddiseases, rare reproductive disease, rare gastrointestinal diseases, rare skin diseases, rare muscle diseases, rare bone diseases;cell culture media for cultivating human, animal, plant or microorganism cells for use in the biotechnological industry
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [001]
Chemical Products
Reagents for scientific purposes for use in nucleic acid isolation and purification; cell culture media for laboratory use for use inthe biotechnological industry; diagnostic reagents for clinical laboratory use; diagnostic preparations for clinical laboratory use
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 97590585
Mark Type
No Service/Collective Mark
Attorney Docket Number
No TORYS-97-122
44D Filed
Yes
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Design Code(s)
26.01.09 -
Geometric figures, objects, humans, plants or animals forming or bordering the perimeter of a circle
26.01.18 -
Three or more concentric circles
26.01.21 -
Circles that are totally or partially shaded
Legal History
| Status Date | Action Taken |
|---|---|
| 05th Nov 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 10th Sep 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 10th Sep 2024 | PUBLISHED FOR OPPOSITION |
| 21st Aug 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 01st Aug 2024 | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED |
| 25th Jul 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 25th Jun 2024 | DIVISIONAL PROCESSING COMPLETE |
| 12th Jun 2024 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 06th Apr 2024 | ASSIGNED TO LIE |
| 16th Nov 2023 | TEAS REQUEST TO DIVIDE RECEIVED |